Medication info
TwinTella Tablet 40/10 mg

TwinTella Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
A white and light blue, biconvex, oval double-layer tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201901207 · Approved 2019.02.26 · Insurance code 670501370

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine); however, direct switching to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients requiring careful administration'). In elderly patients aged 75 years or older, clearance of amlodipine is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
Administration of this drug is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication assists in effectively lowering blood pressure in patients with essential hypertension, where blood pressure is not adequately controlled by either telmisartan or amlodipine monotherapy. It is used to reduce the risk of complications related to hypertension and to improve cardiovascular health.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine); however, direct switching to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients requiring careful administration'). In elderly patients aged 75 years or older, clearance of amlodipine is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

Administration of this drug is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, the use of this medication should be discontinued as soon as possible. Individuals allergic to the main ingredients of this medication or similar constituents, women who are pregnant or may become pregnant, and women who are breastfeeding should not use it. Patients with severe liver dysfunction, specific heart diseases, and severe hypotension should also refrain from taking this medication. During the administration of this medication, liver function, kidney function, and blood pressure status should be carefully monitored, particularly in elderly patients or those with renal impairment. Symptoms of hypotension, such as excessively low blood pressure, may occur, and if such symptoms arise, immediate rest in a lying position is advised, and hospital treatment should be sought if necessary. This medication can increase blood potassium levels, so caution is needed when taken with potassium-rich medications or supplements. Dizziness and drowsiness may occur while taking this medication, which necessitates caution when operating vehicles or machinery. There may be interactions with other medications; thus, consultation with a doctor or pharmacist is mandatory, especially for those taking antihypertensives, diuretics, anticoagulants, or heart medications. In cases of overdose, severe hypotension, dizziness, and irregular heartbeats may occur, requiring immediate emergency treatment. This medication is not recommended for children, and during storage, it should be kept out of reach of children and protected from moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 93 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste disturbances
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • eczema
  • erythema
  • hair loss
  • purpura
  • skin discoloration
  • sweating
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that can block light and air, and it is recommended to store it at room temperature between 1 degree to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for an extended period.

Appearance and packaging

Appearance

A white and light blue, biconvex, oval double-layer tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.